Literature DB >> 19691290

Subtractive proteomic approach to the endometrial carcinoma invasion front.

Marta Monge1, Andreas Doll, Eva Colas, Antonio Gil-Moreno, Josep Castellvi, Angel Garcia, Nuria Colome, Asummpcio Perez-Benavente, Nuria Pedrola, Rafael Lopez-Lopez, Xavier Dolcet, Santiago Ramon y Cajal, Jordi Xercavins, Xavier Matias-Guiu, Francesc Canals, Jaume Reventos, Miguel Abal.   

Abstract

Tumor invasion defines the transition between tissue-restricted carcinomas, related to good outcome as optimal surgery becomes possible, and metastatic tumors associated with poor prognosis and a dramatic decrease in survival. In endometrial cancer, myometrial infiltration represents a determinant parameter highly valuable in prognosis. To date, the identification of proteins involved in endometrial carcinoma invasion has been essentially conducted by immunohistochemical methods, without a global perception on the invasive front. Laser microdissection presents nowadays limitations to the profound spatiotemporal regulation from both the tumor and the surrounding stroma occurring at the invasive front. In this work, we attempted an alternative proteomic approach to characterize specific components of the tumor invasive front or its reactive stroma, by comparing the invasive area of an endometrial carcinoma with the noninvasive superficial tumor area and normal tissue from the same patients. This strategy led us to identify proteins involved in cellular morphology, assembly and movement, differentially expressed at the invasive front, as well as pathways like cell-to-cell signaling and interaction and a modulated response to oxidative stress as events related to endometrial carcinoma invasion. In conclusion, we could identify new players of myometrial infiltration by applying a subtractive proteomic approach to the endometrial carcinoma invasion front.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19691290     DOI: 10.1021/pr900390t

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  6 in total

Review 1.  The EMT signaling pathways in endometrial carcinoma.

Authors:  Eva Colas; Nuria Pedrola; Laura Devis; Tugçe Ertekin; Irene Campoy; Elena Martínez; Marta Llauradó; Marina Rigau; Mireia Olivan; Marta Garcia; Silvia Cabrera; Antonio Gil-Moreno; Jordi Xercavins; Josep Castellvi; Angel Garcia; Santiago Ramon y Cajal; Gema Moreno-Bueno; Xavier Dolcet; Francesc Alameda; Jose Palacios; Jaime Prat; Andreas Doll; Xavier Matias-Guiu; Miguel Abal; Jaume Reventos
Journal:  Clin Transl Oncol       Date:  2012-08-22       Impact factor: 3.405

2.  Characterization of the molecular changes associated with the overexpression of a novel epithelial cadherin splice variant mRNA in a breast cancer model using proteomics and bioinformatics approaches: identification of changes in cell metabolism and an increased expression of lactate dehydrogenase B.

Authors:  Marina Rosso; Lara Lapyckyj; María José Besso; Marta Monge; Jaume Reventós; Francesc Canals; Jorge Oswaldo Quevedo Cuenca; María Laura Matos; Mónica Hebe Vazquez-Levin
Journal:  Cancer Metab       Date:  2019-05-09

3.  Characterization of cytoplasmic cyclin D1 as a marker of invasiveness in cancer.

Authors:  Noel P Fusté; Esmeralda Castelblanco; Isidre Felip; Maria Santacana; Rita Fernández-Hernández; Sònia Gatius; Neus Pedraza; Judit Pallarés; Tània Cemeli; Joan Valls; Marc Tarres; Francisco Ferrezuelo; Xavier Dolcet; Xavier Matias-Guiu; Eloi Garí
Journal:  Oncotarget       Date:  2016-05-10

4.  Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism.

Authors:  Mariona Jové; Sònia Gatius; Andree Yeramian; Manuel Portero-Otin; Núria Eritja; Maria Santacana; Eva Colas; Maria Ruiz; Reinald Pamplona; Xavier Matias-Guiu
Journal:  Oncotarget       Date:  2016-08-09

Review 5.  Heme-Derived Metabolic Signals Dictate Immune Responses.

Authors:  Giacomo Canesin; Seyed M Hejazi; Kenneth D Swanson; Barbara Wegiel
Journal:  Front Immunol       Date:  2020-01-31       Impact factor: 7.561

Review 6.  Proteomic Biomarkers for the Detection of Endometrial Cancer.

Authors:  Kelechi Njoku; Davide Chiasserini; Anthony D Whetton; Emma J Crosbie
Journal:  Cancers (Basel)       Date:  2019-10-16       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.